CVS Health
CVS
Market cap $81.9B

64.78 USD

-0.84

1.28%

At close Jul 11, 4:00 PM EDT

After hours

64.80

+0.02

0.03%

1 day

-1.28%

5 days

-3.60%

1 month

-1.43%

3 months

-6.80%

6 months

25.74%

Year to date

46.49%

1 year

11.29%

5 years

3.45%

10 years

-40.66%

About: CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 27 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all existing business lines.

Employees: 300,000

Healthcare Healthcare Plans

0

Funds holding %

of 7,312 funds

0

Analysts bullish %

of 7 analysts

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

177% more funds holding in top 10

Funds holding in top 10: 13 [Q4 2024] → 36 (+23) [Q1 2025]

65% more first-time investments, than exits

New positions opened: 274 | Existing positions closed: 166

53% more capital invested

Capital invested by funds: $47.2B [Q4 2024] → $72B (+$24.9B) [Q1 2025]

5% more funds holding

Funds holding: 1,636 [Q4 2024] → 1,717 (+81) [Q1 2025]

1.27% more ownership

Funds ownership: 83.08% [Q4 2024] → 84.35% (+1.27%) [Q1 2025]

7% more call options, than puts

Call options by funds: $2.18B | Put options by funds: $2.05B

29% less repeat investments, than reductions

Existing positions increased: 525 | Existing positions reduced: 744

See Fund Rankings

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$71

10%

upside

Avg. target

$79

21%

upside

High target

$84

30%

upside

7 analyst ratings

5 positive

71%

2 neutral

29%

0 negative

0%

Jefferies Brian Tanquilut	23%upside $80	Buy Maintained	30 Jun 2025
Barclays Andrew Mok	22%upside $79	Overweight Maintained	2 Jun 2025
Truist Securities David Macdonald	30%upside $84	Buy Maintained	12 May 2025
Wells Fargo Stephen Baxter	30%upside $84	Overweight Maintained	6 May 2025
RBC Capital Ben Hendrix	25%upside $81	Outperform Maintained	5 May 2025

See Analyst Rankings

Financial journalist opinion

Based on 44 articles about CVS published over the past 30 days

EngageWell, Rocket Doctor, and CVS Health Foundation Launch Virtual Healthy Aging Program for Adults over 60

Health checks include assessments for heart health, memory, cognitive function, and mental health No travel required — all appointments are virtual and confidential Community Health Workers provide personalized follow-up support and connect patients to local resources The program is now available in New York City, with plans to expand throughout 2025 Free for patients on Medicaid, covered by insurance for patients on Medicare New York, NY, July 10, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce that building off their successful graduation from AARPs AgeTech Accelerator, its subsidiary, Rocket Doctor Inc., has partnered with EngageWell IPA in a program funded by CVS Health (NYSE: CVS ) Foundation to launch the Healthy Aging Program — a new pilot initiative offering virtual health screenings for adults aged 60 and older across New York City. Funded through a 5-year, $1M grant from the CVS Health® Foundation, EngageWell and Rocket Doctor's program is designed to support older adults in maintaining their health and independence.

EngageWell, Rocket Doctor, and CVS Health Foundation Launch Virtual Healthy Aging Program for Adults over 60

Zacks Investment Research

Here's Why CVS Health (CVS) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Here's Why CVS Health (CVS) is a Strong Value Stock

Zacks Investment Research

Is CVS Moving Closer to Reaching Its Long-Term Low 3X Leverage Goal?

CVS Health inches closer to its long-term leverage target, helped by Aetna margin recovery and disciplined cash use.

Is CVS Moving Closer to Reaching Its Long-Term Low 3X Leverage Goal?

Judge orders CVS' Omnicare unit to pay $949 million over invalid prescriptions

A federal judge ordered CVS Health's Omnicare unit to pay $948.8 million in penalties and damages, in a whistleblower lawsuit claiming it fraudulently billed the U.S. government for invalid drug prescriptions.

Judge orders CVS' Omnicare unit to pay $949 million over invalid prescriptions

Zacks Investment Research

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

CVS Health declares quarterly dividend

WOONSOCKET, R.I. , July 7, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation.

CVS Health declares quarterly dividend

Zacks Investment Research

Can CVS Sustain Pharmacy & Consumer Wellness Gains Through Year-End?

CVS Health's CVS Pharmacy and Consumer Wellness (“PCW”) segment has seen steady growth in recent months, with revenues up 11.1% year over year in the first quarter of 2025. Performance was supported by seasonal trends, including the impact of high vaccine demand and a longer-than-usual flu season.

Can CVS Sustain Pharmacy & Consumer Wellness Gains Through Year-End?

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

Zacks Investment Research

CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know

CVS Health (CVS) closed at $66.6 in the latest trading session, marking a -4.28% move from the prior day.

CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know

Zacks Investment Research

Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?

See News Rankings

Charts implemented using Lightweight Charts™